XWELL (XWEL) Projected to Announce Quarterly Earnings on Wednesday

XWELL (NASDAQ:XWEL) is expected to announce its Q3 2026 results on Wednesday, November 18th. Analysts expect the company to announce earnings of ($1.00) per share and revenue of $2.37 million for the quarter. Parties are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Friday, November 20, 2026 at 4:00 PM ET.

XWELL (NASDAQ:XWEL) last released its earnings results on Friday, August 14th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.00) by $0.74. The company had revenue of $7.15 million during the quarter, compared to the consensus estimate of $2.37 million. XWELL had a negative return on equity of 1,091.48% and a negative net margin of 82.90%.

XWELL Price Performance

Shares of XWEL opened at $0.54 on Wednesday. The firm has a market cap of $5.71 million, a P/E ratio of -0.10 and a beta of 1.04. The stock has a 50 day simple moving average of $0.81 and a two-hundred day simple moving average of $1.00. XWELL has a 1 year low of $0.26 and a 1 year high of $2.20.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of XWELL from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, November 3rd. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

About XWELL

XWELL Corp. (NASDAQ:XWEL) is a health and wellness services company focused on providing convenient, consumer-oriented care in travel and other high-traffic environments. The company is best known for XpresSpa, a wellness brand that offers services such as massages, facials, nail care and related relaxation treatments, primarily at airports. The company was formerly known as XpresSpa Group and changed its name to XWELL in 2023 to reflect a broader focus on wellness and health-related services. During the COVID-19 pandemic, the company expanded into health screening and testing through its XpresCheck business.